O	0	4	Does
O	5	8	the
O	9	12	use
O	13	15	of
B-intervention	16	22	fibrin
I-intervention	23	27	glue
O	28	35	prevent
B-condition	36	42	seroma
I-condition	43	52	formation
O	53	58	after
O	59	67	axillary
O	68	83	lymphadenectomy
O	84	87	for
O	88	94	breast
O	95	101	cancer
O	101	102	?

O	103	104	A
O	105	116	prospective
O	117	127	randomized
O	128	133	trial
O	134	136	in
B-total-participants	137	140	159
O	141	149	patients
O	149	150	.

O	151	157	Seroma
O	158	167	formation
O	168	178	frequently
O	179	185	occurs
O	186	188	in
O	189	197	patients
O	198	201	who
O	202	206	have
O	207	216	undergone
O	217	225	axillary
O	226	241	lymphadenectomy
O	241	242	.

O	243	246	The
O	247	250	aim
O	251	253	of
O	254	257	the
O	258	263	study
O	264	267	was
O	268	270	to
O	271	279	evaluate
O	280	283	the
O	284	290	effect
O	291	293	of
O	294	300	fibrin
O	301	305	glue
O	306	308	in
O	309	312	the
O	313	323	prevention
O	324	326	of
O	327	333	seroma
O	334	343	formation
O	344	349	after
O	350	358	axillary
O	359	374	lymphadenectomy
O	374	375	.

B-total-participants	376	383	Hundred
I-total-participants	384	389	fifty
I-total-participants	389	390	-
I-total-participants	390	394	nine
B-eligibility	395	401	breast
I-eligibility	402	408	cancer
I-eligibility	409	417	patients
I-eligibility	418	423	about
I-eligibility	424	426	to
I-eligibility	427	434	undergo
I-eligibility	435	449	quadrantectomy
I-eligibility	450	452	or
I-eligibility	453	463	mastectomy
I-eligibility	464	468	plus
I-eligibility	469	477	axillary
I-eligibility	478	493	lymphadenectomy
O	494	498	were
O	499	507	enrolled
O	508	510	in
O	511	514	the
O	515	520	study
O	521	524	and
O	525	535	randomized
O	536	540	into
O	541	544	two
O	545	551	groups
O	551	552	.

O	553	559	Fibrin
O	560	564	glue
O	565	570	spray
O	571	578	applied
O	579	581	to
O	582	585	the
O	586	594	axillary
O	595	600	fossa
O	601	605	plus
O	606	615	placement
O	616	618	of
O	619	625	closed
O	626	633	suction
O	634	642	drainage
O	643	647	were
O	648	652	used
O	653	655	in
B-intervention-participants	656	658	80
O	659	667	patients
O	668	669	(
O	669	674	group
O	675	676	A
O	676	677	)
O	677	678	;
B-control	679	688	placement
I-control	689	691	of
I-control	692	698	closed
I-control	699	706	suction
I-control	707	715	drainage
O	716	719	was
O	720	724	only
O	725	729	used
O	730	732	in
B-control-participants	733	735	79
O	736	744	patients
O	745	746	(
O	746	751	group
O	752	753	B
O	753	754	)
O	754	755	.

O	756	761	Group
O	762	763	A
O	764	772	patients
O	773	779	showed
O	780	781	a
O	782	788	slight
O	789	798	advantage
O	799	803	with
O	804	810	regard
O	811	813	to
O	814	817	the
O	818	822	mean
O	823	831	duration
O	832	834	of
O	835	843	axillary
O	844	852	drainage
O	853	862	placement
O	863	864	(
B-iv-cont-mean	864	865	4
I-iv-cont-mean	865	866	.
I-iv-cont-mean	866	867	5
O	868	869	+
O	869	870	/
O	870	871	-
B-iv-cont-sd	872	873	1
I-iv-cont-sd	873	874	.
I-iv-cont-sd	874	875	3
I-iv-cont-sd	876	880	days
O	881	883	in
O	884	889	group
O	890	891	A
O	892	894	vs
O	894	895	.
B-cv-cont-mean	896	897	5
I-cv-cont-mean	897	898	.
I-cv-cont-mean	898	899	1
O	900	901	+
O	901	902	/
O	902	903	-
B-cv-cont-sd	904	905	1
I-cv-cont-sd	905	906	.
I-cv-cont-sd	906	907	6
I-cv-cont-sd	908	912	days
O	913	915	in
O	916	921	group
O	922	923	B
O	923	924	)
O	925	928	and
B-outcome	929	935	number
I-outcome	936	938	of
I-outcome	939	945	seroma
I-outcome	946	957	aspirations
O	958	959	(
B-iv-cont-mean	959	960	6
I-iv-cont-mean	960	961	.
I-iv-cont-mean	961	962	3
O	963	964	+
O	964	965	/
O	965	966	-
B-iv-cont-sd	967	968	1
I-iv-cont-sd	968	969	.
I-iv-cont-sd	969	970	1
O	971	973	in
O	974	979	group
O	980	981	A
O	982	984	vs
O	984	985	.
B-cv-cont-mean	986	987	6
I-cv-cont-mean	987	988	.
I-cv-cont-mean	988	989	7
O	990	991	+
O	991	992	/
O	992	993	-
B-cv-cont-sd	994	995	1
I-cv-cont-sd	995	996	.
I-cv-cont-sd	996	997	2
O	998	1000	in
O	1001	1006	group
O	1007	1008	B
O	1008	1009	)
O	1009	1010	.

O	1011	1013	No
O	1014	1027	statistically
O	1028	1039	significant
O	1040	1051	differences
O	1052	1056	were
O	1057	1065	observed
O	1066	1073	between
O	1074	1077	the
O	1078	1081	two
O	1082	1088	groups
O	1089	1091	of
O	1092	1100	patients
O	1101	1110	regarding
O	1111	1114	the
O	1115	1119	mean
B-outcome	1120	1126	volume
I-outcome	1127	1129	of
I-outcome	1130	1135	total
I-outcome	1136	1144	axillary
I-outcome	1145	1153	drainage
O	1154	1157	and
O	1158	1160	of
B-outcome	1161	1166	total
I-outcome	1167	1173	seroma
I-outcome	1174	1180	volume
O	1180	1181	.

O	1182	1185	The
O	1186	1189	use
O	1190	1192	of
O	1193	1199	fibrin
O	1200	1204	glue
O	1205	1209	does
O	1210	1213	not
O	1214	1221	prevent
O	1222	1228	seroma
O	1229	1238	formation
O	1239	1242	and
O	1243	1247	does
O	1248	1251	not
O	1252	1258	reduce
O	1259	1265	seroma
O	1266	1275	magnitude
O	1276	1279	and
O	1280	1288	duration
O	1288	1289	.

O	1290	1293	The
O	1294	1299	costs
O	1300	1302	of
O	1303	1306	the
O	1307	1314	product
O	1315	1323	involved
O	1324	1326	do
O	1327	1330	not
O	1331	1338	justify
O	1339	1342	its
O	1343	1350	routine
O	1351	1354	use
O	1355	1357	in
O	1358	1366	patients
O	1367	1377	undergoing
O	1378	1386	axillary
O	1387	1397	dissection
O	1397	1398	.
